Travis Farmer, MD
Surgery of the Hand · Rincon, GANPI 1346564234
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (57.5%), education and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 65.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $10,071 and has fallen 98.9% since, to $115 in 2025.
Across 38 payments — averaging $457.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$11K
- Medinc Of Texas$3K
- Team 1, LLC$1K
- Axogen$959
- Stryker$484
- Smith+Nephew$293
- plus $511 from 6 others
What the payments were for
- Grants$10,00057%
- Travel & lodging$5493%
- Food & beverage$1,91011%
- Education$4,93728%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 4 | $11,412 |
| Medinc Of Texas | 2 | $2,537 |
| Team 1, LLC | 1 | $1,200 |
| Axogen | 6 | $959 |
| Stryker | 9 | $484 |
| Smith+Nephew | 6 | $293 |
| Skeletal Dynamics Inc | 3 | $198 |
| Endo Pharmaceuticals Inc. | 3 | $151 |
| Acumed LLC | 1 | $97 |
| Integra Lifesciences Corporation | 1 | $24 |
| Arthrosurface Incorporated | 1 | $24 |
| Dynasplint Systems Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AxoGuard Nerve Protector$704
- AxoGuard Nerve Connector$704
- T2$151
- EVOS$134
- TRIGEN InterTAN$134
- Geminus$118
- Align$118
- IJS$118
- Implate$118
- XIAFLEX$117
- GAMMA$115
How this compares
Too few surgery of the hand providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 72 | $1,153 |
| Diclofenac Sodium | 13 | $1,151 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 129 | $902 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 43 | $519 |
| Methylprednisolone | 60 | $339 |
| Doxycycline Hyclate | 13 | $124 |
| Ibuprofen | 22 | $114 |
| Tramadol Hcl | 53 | $103 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 21 | $95 |
| Meloxicam | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Other surgery of the hand in Rincon
- Snehal DalalJohns Creek$20K
- Daniel HoltzAcworth$6K
- Trevor StarnesMarietta$5K
- Brandy CrossMarietta$5K
- Cesar Molina AndradeSmyrna$5K
- Samuel PayneAtlanta$2K
- Virginia JonesNewnan$2K
- Amit PatelSmyrna$566
- Steven WatsonSmyrna$146
- Michael MangononNorcross$36
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.